| Name | Economy Drug |
|---|---|
| Organization Name | Gwl Inc |
| Location | 1006 W Trimble Ave, Berryville, Arkansas 72616 |
| Type | Pharmacy |
| Phone | (870) 423-2094 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.
Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.
The TriZetto Group, Inc. today announced that Hallmark Insights, a wholly owned subsidiary of Hallmark Cards, Inc., will provide incentive rewards as an integrated component of TriZetto's Value-Based Benefits Solution for healthcare payer organizations. Available in early 2010, TriZetto's software solution will enable health plans using TriZetto's enterprise administration systems to offer employers automated benefit programs that incent members to adopt healthier lifestyles and effectively manage chronic conditions.
› Verified 9 days ago
| NPI Number | 1447364419 |
| Organization Name | GWL INC |
| Doing Business As | ECONOMY DRUG |
| Type | Pharmacy |
| Address | 1006 W Trimble Ave, Berryville, AR 72616 |
| Phone Number | 870-423-2094 |
News Archive
PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.
Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.
The TriZetto Group, Inc. today announced that Hallmark Insights, a wholly owned subsidiary of Hallmark Cards, Inc., will provide incentive rewards as an integrated component of TriZetto's Value-Based Benefits Solution for healthcare payer organizations. Available in early 2010, TriZetto's software solution will enable health plans using TriZetto's enterprise administration systems to offer employers automated benefit programs that incent members to adopt healthier lifestyles and effectively manage chronic conditions.
› Verified 9 days ago
| NPI Number | 1760253561 |
| Organization Name | GWL INC |
| Type | Long Term Care Pharmacy |
| Address | 1006 W Trimble Ave, Berryville, AR 72616 |
| Phone Number | 870-423-2094 |
News Archive
PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.
Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.
The TriZetto Group, Inc. today announced that Hallmark Insights, a wholly owned subsidiary of Hallmark Cards, Inc., will provide incentive rewards as an integrated component of TriZetto's Value-Based Benefits Solution for healthcare payer organizations. Available in early 2010, TriZetto's software solution will enable health plans using TriZetto's enterprise administration systems to offer employers automated benefit programs that incent members to adopt healthier lifestyles and effectively manage chronic conditions.
› Verified 9 days ago
News Archive
PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.
Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.
The TriZetto Group, Inc. today announced that Hallmark Insights, a wholly owned subsidiary of Hallmark Cards, Inc., will provide incentive rewards as an integrated component of TriZetto's Value-Based Benefits Solution for healthcare payer organizations. Available in early 2010, TriZetto's software solution will enable health plans using TriZetto's enterprise administration systems to offer employers automated benefit programs that incent members to adopt healthier lifestyles and effectively manage chronic conditions.
› Verified 9 days ago
Berryville Eyecare Clinic Type: Medicare Supplier Location: 404 West College Ave, Berryville, Arkansas 72616 Phone: (870) 423-2576 | |
Economy Drug Type: Pharmacy Location: 1006 W Trimble Ave, Berryville, Arkansas 72616 Phone: (870) 423-2094 | |
Wal-mart Pharmacy 10-0076 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1000 W Trimble Ave, Berryville, Arkansas 72616 Phone: (870) 423-6611 |